Published Date : Sep 26, 2016
Albany, NY, Sep 26, 2016: MarketResearchReports.biz has announced the addition of an intelligence report, titled “EpiCast Report: Atrial Fibrillation - Epidemiology Forecast To 2025,” to its offerings. The report offers insights into various methods used to carry out epidemiology of atrial fibrillation (AF) in eight major markets (8MM), which are the U.S., the U.K., France, Italy, Germany, Japan, Spain, and Canada. Inputs from several masters- and PhD-level epidemiologists were taken into consideration while collating this study.
As per the findings of the report, the number of diagnosed cases of atrial fibrillation across the 8MM will increase to 11,536,773 in 2025 from 9,487,217 in 2015, rising at an annual growth rate of 2.16% from 2016 to 2025. The U.S. is expected to be the most lucrative market owing to the fact that the country will have the highest number of diagnosed cases of atrial fibrillation among the 8MM. Other factors fuelling the growth of this regional market are the soaring disposable income of patients coupled with robust reimbursement frameworks, increasing patient awareness, and rising penetration of non-pharmacological procedures. However, increasing competition in mature markets will impel AF catheter ablation device manufacturers to shift focus towards emerging markets in the forthcoming years.
The growth of the AF market is encouraging the epidemiology of this disorder. The growing cases of people suffering from AF are the key driving force of this market. Moreover, the rising incidence of brain damage and strokes along with an increasing geriatric population are encouraging the growth of the AF market in the 8MM. Furthermore, the lower treatment cost and conducive regulations are supporting the increasing number of atrial fibrillation surgical and catheter ablation procedures, especially in France.
For Sample Copy, click here: http://www.marketresearchreports.biz/sample/sample/785535
For a coherent understanding of the current trends, the authors of the report have segmented the market using different criteria and derived the growth trajectory across the 8MM. Based on clinical subtypes, the market is segmented into permanent, paroxysmal, and persistent AF. Permanent AF was the leading segment in 2015 and is forecast to remain dominant until 2025. In the U.K., the U.S., Germany, Japan, Canada, and Spain, paroxysmal AF is expected to be the second largest subtype, while persistent AF is the second largest segment in Italy and France. Other criteria used for segmentation are age and sex.
The report provides a comprehensive evaluation of global trends influencing the growth of the market in the 8MM. It presents insights into the methodology used to carry out the research along with a description of assumptions and other indicators. Information from a number of presentations, press releases, paid databases, journals, and white papers has been taken into account for the compilation of the report. It serves as an effective tool of guidance for existing and new market players in developing business strategies.
To order report Call Toll Free: 866-997-4948 or send an email on firstname.lastname@example.org